ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,367.82
0.00%
Dow Jones
40,842.79
0.00%
Gold vs US Dollar
2,442.07
-0.15%
Brent Oil
81.275
-0.29%
Bitcoin
64,751.12
0.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Compass Pathways Plc (5Y6) Share Price

5Y6 Compass Pathways Plc

7.10
0.05 (0.71%)
11:50:47 - Realtime Data
 Name  Symbol  Market  Type  ISIN  Description 
 Compass Pathways Plc TG:5Y6 Tradegate (DE) Ordinary Share  ADR
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time  RN  NRN 
   0.05 0.71 7.10 7.10 7.25 7.10 7.10 7.1 285 10:50:47   
 Type  Size  Price  Time  Units 
  281 7.10 08:31:53 EUR
 
Recent News
DateTimeSource
HeadlineMore 5Y6 News
01/08/202411:30UKREGCompass Pathways announces second quarter 2024 financial results and business highlights
26/06/202411:30GLOBECompass Pathways appoints Lori Englebert as Chief Commercial Officer
08/05/202411:45GLOBECompass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
08/05/202411:30GLOBECompass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
02/05/202411:30GLOBECompass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
29/04/202411:30GLOBECompass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
28/03/202412:00GLOBECompass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
Period
Draw mode
Data Downloads for 5Y6

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Compass Pathways Plc Articles